Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Financement
Se connecter S’enregistrer
Mode nuit
Triple-Negative Breast Cancer: The Frontline of Innovation in HER2 Negative Disease
Within the HER2 negative breast cancer category, triple-negative breast cancer (TNBC) stands out as the most aggressive and historically most challenging subtype. Lacking estrogen receptors, progesterone receptors, and HER2 expression, TNBC doesn't respond to targeted therapies that benefit other breast cancer types, leaving chemotherapy as the mainstay for decades. That's changing...
0 Commentaires ·0 Parts ·13 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!